Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
change in the taste of food or drink Constipation decreased appetite Diarrhea dizziness gas or burping heartburn mild abdominal pain or bloating nausea redness, itching, or swelling at the injection site tiredness vomiting weight loss Although most of the side effects listed below dont happen very often, they could lead to serious problems if you do not seek medical attention
105 TuckerJ
Researchers concluded this could be because females have a lower average body weight compared to males, which allowed for more exposure to the drug
Retatrutide is an investigational medication that hasnt been approved by the MHRA
Individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) are contraindicated due to mechanistic overlap with GLP-1 agonists
Usage & Storage Description Retatrutide is a novel triple receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously
US$ 23.88
US$ 29.45
US$ 21.39
US$ 26.11
US$ 28.83
US$ 28.81
US$ 20.00
US$ 21.18
